Bridget E. Bunner

Array ( [id] => 6097437 [patent_doc_number] => 20110003746 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-06 [patent_title] => 'Protein variants' [patent_app_type] => utility [patent_app_number] => 11/512046 [patent_app_country] => US [patent_app_date] => 2006-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 23690 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20110003746.pdf [firstpage_image] =>[orig_patent_app_number] => 11512046 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5171804 [patent_doc_number] => 20070072236 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-29 [patent_title] => 'Novel type II Na/Pi cotransporters and type II Na/Pi cotransporter expression regulatory factors' [patent_app_type] => utility [patent_app_number] => 11/508069 [patent_app_country] => US [patent_app_date] => 2006-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 18064 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20070072236.pdf [firstpage_image] =>[orig_patent_app_number] => 11508069 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5016216 [patent_doc_number] => 20070259425 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-08 [patent_title] => 'Stem cell derived factors for treating pathologic conditions' [patent_app_type] => utility [patent_app_number] => 11/508010 [patent_app_country] => US [patent_app_date] => 2006-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 16533 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0259/20070259425.pdf [firstpage_image] =>[orig_patent_app_number] => 11508010 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5182950 [patent_doc_number] => 20070054297 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-08 [patent_title] => 'Mammalian relaxin receptors' [patent_app_type] => utility [patent_app_number] => 11/497641 [patent_app_country] => US [patent_app_date] => 2006-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 15638 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20070054297.pdf [firstpage_image] =>[orig_patent_app_number] => 11497641 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 299560 [patent_doc_number] => 07537758 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-05-26 [patent_title] => 'Antibodies against a peptide epitope of apolipoprotein B' [patent_app_type] => utility [patent_app_number] => 11/485549 [patent_app_country] => US [patent_app_date] => 2006-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11451 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/537/07537758.pdf [firstpage_image] =>[orig_patent_app_number] => 11485549 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6449669 [patent_doc_number] => 20100145006 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'SUPRAVALENT COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 11/917991 [patent_app_country] => US [patent_app_date] => 2006-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 23645 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0145/20100145006.pdf [firstpage_image] =>[orig_patent_app_number] => 11917991 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5416903 [patent_doc_number] => 20090042790 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-12 [patent_title] => 'TRANSMUCOSAL DELIVERY OF PEPTIDE DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 11/917340 [patent_app_country] => US [patent_app_date] => 2006-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7955 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20090042790.pdf [firstpage_image] =>[orig_patent_app_number] => 11917340 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5857873 [patent_doc_number] => 20060228341 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-12 [patent_title] => 'Pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/450244 [patent_app_country] => US [patent_app_date] => 2006-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9773 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0228/20060228341.pdf [firstpage_image] =>[orig_patent_app_number] => 11450244 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5888826 [patent_doc_number] => 20060275838 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-07 [patent_title] => 'Compositions and methods for inhibiting liver stellate cell growth' [patent_app_type] => utility [patent_app_number] => 11/436384 [patent_app_country] => US [patent_app_date] => 2006-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 10722 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20060275838.pdf [firstpage_image] =>[orig_patent_app_number] => 11436384 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5704811 [patent_doc_number] => 20060193859 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-31 [patent_title] => 'Methods of Treatment Using Antibodies to Neutrokine-alpha' [patent_app_type] => utility [patent_app_number] => 11/382837 [patent_app_country] => US [patent_app_date] => 2006-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 162614 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0193/20060193859.pdf [firstpage_image] =>[orig_patent_app_number] => 11382837 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5661063 [patent_doc_number] => 20060251659 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-09 [patent_title] => 'Method for screening molecules that restore NOD1 activity in cells containing an NOD2 mutation that reduces or eliminates NOD1 activity' [patent_app_type] => utility [patent_app_number] => 11/399477 [patent_app_country] => US [patent_app_date] => 2006-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 6916 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0251/20060251659.pdf [firstpage_image] =>[orig_patent_app_number] => 11399477 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5682514 [patent_doc_number] => 20060198784 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-07 [patent_title] => 'Methods of treatment using antibodies to Neutrokine-alpha' [patent_app_type] => utility [patent_app_number] => 11/377165 [patent_app_country] => US [patent_app_date] => 2006-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 162694 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0198/20060198784.pdf [firstpage_image] =>[orig_patent_app_number] => 11377165 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5851153 [patent_doc_number] => 20060234344 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-19 [patent_title] => 'Protein kinases' [patent_app_type] => utility [patent_app_number] => 11/377316 [patent_app_country] => US [patent_app_date] => 2006-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 120 [patent_figures_cnt] => 120 [patent_no_of_words] => 91996 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11377316 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5479593 [patent_doc_number] => 20090202550 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-13 [patent_title] => 'MONOCLONAL ANTIBODIES AND IMMUNODETECTION ASSAY SPECIFIC FOR THE CHEMOTACTIC EPITOPE OF THE UROKINASE-TYPE PLASMINOGEN ACTIVATOR RECEPTOR' [patent_app_type] => utility [patent_app_number] => 11/814093 [patent_app_country] => US [patent_app_date] => 2006-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 13564 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20090202550.pdf [firstpage_image] =>[orig_patent_app_number] => 11814093 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5625298 [patent_doc_number] => 20060263803 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-23 [patent_title] => 'Stem cell growth factor-like polypeptides' [patent_app_type] => utility [patent_app_number] => 11/368304 [patent_app_country] => US [patent_app_date] => 2006-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 47524 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20060263803.pdf [firstpage_image] =>[orig_patent_app_number] => 11368304 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 352513 [patent_doc_number] => 07491533 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-02-17 [patent_title] => 'Polynucleotides encoding an isolated β-islet cell two-pore domain potassium channel' [patent_app_type] => utility [patent_app_number] => 11/367182 [patent_app_country] => US [patent_app_date] => 2006-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 23359 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/491/07491533.pdf [firstpage_image] =>[orig_patent_app_number] => 11367182 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5330204 [patent_doc_number] => 20090110681 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-30 [patent_title] => 'Anti-M-CSF Antibody Compositions' [patent_app_type] => utility [patent_app_number] => 11/817993 [patent_app_country] => US [patent_app_date] => 2006-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 42518 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20090110681.pdf [firstpage_image] =>[orig_patent_app_number] => 11817993 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5857890 [patent_doc_number] => 20060228352 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-12 [patent_title] => 'TRAIL and methods of modulating T cell activity and adaptive immune responses using TRAIL' [patent_app_type] => utility [patent_app_number] => 11/361307 [patent_app_country] => US [patent_app_date] => 2006-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 36614 [patent_no_of_claims] => 99 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0228/20060228352.pdf [firstpage_image] =>[orig_patent_app_number] => 11361307 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5632579 [patent_doc_number] => 20060149049 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-06 [patent_title] => 'Stem cell growth factor-like ployeptides' [patent_app_type] => utility [patent_app_number] => 11/356373 [patent_app_country] => US [patent_app_date] => 2006-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 47517 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0149/20060149049.pdf [firstpage_image] =>[orig_patent_app_number] => 11356373 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5760655 [patent_doc_number] => 20060211600 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-21 [patent_title] => 'Stem cell-derived factors for treating pathologic conditions' [patent_app_type] => utility [patent_app_number] => 11/350978 [patent_app_country] => US [patent_app_date] => 2006-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8810 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0211/20060211600.pdf [firstpage_image] =>[orig_patent_app_number] => 11350978 [rel_patent_id] =>[rel_patent_doc_number] =>)